Evogene Sells Lavie Bio Assets to ICL for $15.25M

Ticker: EVGN · Form: 6-K · Filed: Apr 21, 2025 · CIK: 1574565

Sentiment: neutral

Topics: acquisition, divestiture, subsidiary sale, agriculture-tech

Related Tickers: ICL

TL;DR

Evogene sells Lavie Bio to ICL for $15.25M + AI tech.

AI Summary

On April 21, 2025, Evogene Ltd. announced the sale of most of its subsidiary Lavie Bio Ltd.'s activities to Dead Sea Works Ltd., an affiliate of ICL Group Ltd., for $15.25 million. Additionally, ICL will acquire Evogene's MicroBoost AI Tech-Engine for the agriculture sector.

Why It Matters

This transaction represents a significant divestiture for Evogene, potentially allowing them to focus on other strategic areas while ICL expands its agricultural technology portfolio.

Risk Assessment

Risk Level: medium — The sale of a subsidiary and technology indicates a strategic shift, which carries inherent business risks and uncertainties.

Key Numbers

Key Players & Entities

FAQ

What specific activities of Lavie Bio Ltd. are being acquired by Dead Sea Works Ltd.?

The filing states that 'most of the activity' of Lavie Bio Ltd. is being acquired, but does not specify the exact activities.

What is the purpose of the MicroBoost AI Tech-Engine?

The filing mentions it is for the 'agriculture field', but does not provide further details on its specific function or application.

What is the total value of the transaction, including the AI tech?

The filing specifies $15.25 million for Lavie Bio's activities and states ICL will acquire the MicroBoost AI Tech-Engine for 'approximately' an unspecified amount, so the total is not fully disclosed.

What is the relationship between Dead Sea Works Ltd. and ICL Group Ltd.?

Dead Sea Works Ltd. is described as an affiliate of ICL Group Ltd.

When did this acquisition announcement take place?

The announcement was made on April 21, 2025.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 21, 2025 regarding Evogene Ltd. (EVGN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing